Navigation Links
ImpactRx Appoints Anand Narasimhan Executive Vice President, Operations and Technology

MOUNT LAUREL, N.J., Sept. 27, 2011 /PRNewswire/ -- ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Anand Narasimhan has joined the Company as Executive Vice President, Operations and Technology.  Mr. Narasimhan will have leadership responsibility for all of the Company's information and technology operations.  He will lead the design and execution of the Company's operational and technology initiatives in support of its next phase of growth, including the expansion of its Consulting Analytics business.

Mr. Narasimhan joins ImpactRx from Symphony Services Corporation, Ltd. where he was most recently Senior Vice President for Enterprise Business, the company's largest business unit, with accountability for revenue and P&L performance, M&A activities, product engineering, customer satisfaction and product innovation.  As a founding member of Symphony Services, he was a major contributor to the creation of a high-growth, profitable and market-leading business in product engineering services.  During his time at Symphony, he directed some of the company's largest development undertakings including critical new product development projects in the business performance management and analytics space.

Mr. Narasimhan has extensive experience in leading large, transformational technology and operational initiatives.  His experience includes serving in leadership roles for world-class information organizations, such as Information Resources, Inc. (IRI) and Cambridge Technology Partners.  Over the course of his career, he has developed specialized expertise in the product development and technology space helping companies transform their operations to generate efficiencies and to maximize the value of their information products and analytics to clients.

"We are excited to add Anand's experience and expertise to our senior management team," declared ImpactRx CEO, Greg Ellis. "Anand brings a terrific technology and operational skill set to ImpactRx and we're looking forward to his leadership in helping us further unlock the value of our ImpactData™ and AdvantageBuilder™ data sets to deliver best-in-class analytical solutions to our customers," Ellis continued.  "Our recent acquisition of TargetRx makes Anand's arrival at ImpactRx even more timely.  He will be instrumental in effectively integrating the operations, technologies and capabilities of the two companies and in driving additional value out of the combined company's assets for our clients," said Ellis.

Mr. Narasimhan has a post-graduate diploma in computer applications from the National Center for Computing Techniques in Bangalore and a Bachelor of Engineering degree from A.C. Tech Engineering College in Karaikudi, India.

About ImpactRx

ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry.  Powered by its longitudinal ImpactData™ and its normative AdvantageBuilder™ data assets, ImpactRx's consulting analytics and custom research capabilities provide unparalleled insight into the drivers of physician brand choice within a complete competitive context.  Through its iPhone-connected panel of more than 4000 targeted physicians and its proprietary, state-of-the-art research technology, ImpactRx captures not only physician treatment decisions in response to promotion, but also the attitudes, perceptions and beliefs underlying those decisions.  The integration of its comprehensive behavioral and attitudinal data with its validated and innovative modeling techniques enables ImpactRx to deliver breakthrough solutions to its clients.  These solutions empower clients to improve brand performance by making more informed and effective decisions around marketing strategy, field and channel execution and pre-launch and launch planning.  ImpactRx is a Symphony Technology Group company (  For more information, visit:

Lesley Bailey
Senior Director, Product Development/Marketing
ImpactRx, Inc.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
3. ImpactRx Releases 2010 Oncology Promotion Report
4. ImpactRx Acquired by Symphony Technology Group
5. ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists
6. ImpactRx Names Kjell Nygren Vice President, Analytical Services
7. ImpactRx Measures How Patient Brand Requests Drive Physician Treatment Decisions
8. ImpactRx Acquires TargetRx
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. West Pharmaceutical Services, Inc. Appoints New Director
11. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
Post Your Comments:
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):